Sung Wan Byun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sung Wan Byun has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Ho Yun Lee
Department of Otorhinolaryngology-Head and Neck Surgery, Ewha Womans University School of Medicine, Seoul, Republic of Korea
7 shared publications - Seung-Ho Shin
Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Ewha Womans University, Seoul, Korea
7 shared publications - Zoo Young Lee
Department of Otorhinolaryngology, College of Medicine, Ewha Womans University, Seoul, South Korea
3 shared publications - Eun Hye Kim
Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Ewha Womans University, Seoul, Korea
2 shared publications - Da Jung Jung
Department of Otorhinolaryngology-Head and Neck Surgery, School of Medicine, Kyungpook National University, Daegu, Korea
1 shared publication - Dong Gu Hur
Department of Otorhinolaryngology-Head and Neck Surgery, College of Medicine, Kyung Hee University Medical Center, Seoul, Korea
1 shared publication
Latest Publications
- Open Access
- 1 January 2027
- Published by XMLink in Journal of Korean Medical Science
- Vol. 42
Sequential Inter-institutional Discordance in Auditory Brainstem Response Thresholds During Medicolegal Hearing Disability Evaluation
Lee HY, et al. J Korean Med Sci. 2027 Feb;42:e17. https://doi.org/10.3346/jkms.2027.42.e17
- 1 January 2027
- Published by XMLink in Journal of Korean Medical Science
- Vol. 42
Open AccessSequential Inter-institutional Discordance in Auditory Brainstem Response Thresholds During Medicolegal Hearing Disability Evaluation
Lee HY, et al. J Korean Med Sci. 2027 Feb;42:e17. https://doi.org/10.3346/jkms.2027.42.e17
- Open Access
- 10 September 2026
- Published by Springer Nature in GeroScience
- p. 1-13
Lower bioelectrical phase angle is associated with audiometric hearing loss in middle-aged and older adults
Bioelectrical phase angle is an integrated marker of cellular integrity, fluid distribution, nutritional status, and physiological reserve, but its relationship with objective sensory function in later life remains unclear. This population-based cross-sectional study analyzed adults aged 40 years or older from the 2022–2023 Korea National Health and Nutrition Examination Survey. Whole-body phase angle at 50 kHz was assessed using bioelectrical impedance analysis, and pure-tone audiometry was used to determine better-ear speech-frequency pure-tone average (PTA) and high-frequency hearing thresholds. Survey-weighted linear and logistic regression analyses were conducted after adjustment for age, sex, body mass index, hypertension, diabetes, current smoking, and alcohol ever use. Among 5,436 participants, each 1-degree increase in phase angle was associated with a 1.50-decibel lower better-ear PTA (95% confidence interval [CI], − 1.97 to − 1.02; P < 0.001) and a 1.51-decibel lower better-ear high-frequency threshold (95% CI, − 2.33 to − 0.69; P < 0.001), indicating lower, better hearing thresholds. Higher phase angle was also associated with reduced odds of audiometric hearing loss, defined as better-ear PTA ≥ 25 decibels hearing level (odds ratio, 0.79; 95% CI, 0.68 to 0.92; P = 0.002). Exploratory age-stratified analyses showed that these associations were evident among adults aged 40 years or older but not among participants aged 12–39 years. These findings support further evaluation of bioelectrical phase angle as a complementary research marker linking objective sensory function with systemic reserve in middle-aged and older adults; longitudinal validation is required before any screening application. Graphical abstract
- 10 September 2026
- Published by Springer Nature in GeroScience
- p. 1-13
Open AccessLower bioelectrical phase angle is associated with audiometric hearing loss in middle-aged and older adults
Bioelectrical phase angle is an integrated marker of cellular integrity, fluid distribution, nutritional status, and physiological reserve, but its relationship with objective sensory function in later life remains unclear. This population-based cross-sectional study analyzed adults aged 40 years or older from the 2022–2023 Korea National Health and Nutrition Examination Survey. Whole-body phase angle at 50 kHz was assessed using bioelectrical impedance analysis, and pure-tone audiometry was used to determine better-ear speech-frequency pure-tone average (PTA) and high-frequency hearing thresholds. Survey-weighted linear and logistic regression analyses were conducted after adjustment for age, sex, body mass index, hypertension, diabetes, current smoking, and alcohol ever use. Among 5,436 participants, each 1-degree increase in phase angle was associated with a 1.50-decibel lower better-ear PTA (95% confidence interval [CI], − 1.97 to − 1.02; P < 0.001) and a 1.51-decibel lower better-ear high-frequency threshold (95% CI, − 2.33 to − 0.69; P < 0.001), indicating lower, better hearing thresholds. Higher phase angle was also associated with reduced odds of audiometric hearing loss, defined as better-ear PTA ≥ 25 decibels hearing level (odds ratio, 0.79; 95% CI, 0.68 to 0.92; P = 0.002). Exploratory age-stratified analyses showed that these associations were evident among adults aged 40 years or older but not among participants aged 12–39 years. These findings support further evaluation of bioelectrical phase angle as a complementary research marker linking objective sensory function with systemic reserve in middle-aged and older adults; longitudinal validation is required before any screening application. Graphical abstract
- Open Access
- 1 January 2025
- Published by XMLink in Yonsei Medical Journal
- Vol. 66 (10) , 685-694
Tinnitus Subtyping and Personalized Treatment via Audiometric and Psychometric Clustering
Kim SJ, et al. Yonsei Med J. 2025 Oct;66(10):685-694. https://doi.org/10.3349/ymj.2025.0088
- 1 January 2025
- Published by XMLink in Yonsei Medical Journal
- Vol. 66 (10) , 685-694
Open AccessTinnitus Subtyping and Personalized Treatment via Audiometric and Psychometric Clustering
Kim SJ, et al. Yonsei Med J. 2025 Oct;66(10):685-694. https://doi.org/10.3349/ymj.2025.0088
- Open Access
- 30 November 2023
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 19 (6) , 497-502
Clinical Features of Non-Lateralized Tinnitus
BACKGROUND: We aimed to analyze and confirm the clinical features of patients with non-lateralized tinnitus and to identify clues that can be used in their management. METHODS: Data from 469 patients who visited a university hospital complaining of tinnitus between March 2020 and December 2021 were reviewed. The patients’ medical histories, Tinnitus Handicap Inventory, Beck Depression Inventory, and numerical rating scale scores on tinnitus awareness, annoyance, loudness, and effect on life, audiological profiles, and quantitative electroencephalography findings were documented. RESULTS: Forty-nine (10.4%) patients had non-lateralized tinnitus. They were older and had a shorter duration of symptoms (13.91 ± 34.16 months) than patients with bilateral tinnitus (duration: 39.15 ± 80.82 months) (P < .05). The accompanying symptoms, Tinnitus Handicap Inventory scores, and numerical rating scale scores were not significantly different between the 2 groups (P > .05). Patients with non-lateralized tinnitus had worse hearing at 12 kHz on the left side than those with unilateral tinnitus. Hearing asymmetry was least common in non-lateralized tinnitus (n=11/49, 10.4%), followed by bilateral tinnitus (n=54/198, 42.2%) and unilateral tinnitus (n=97/222, 47.3%) (P< .001). Regarding quantitative electroencephalography, there were significant differences in the absolute power of the theta, alpha, beta, gamma, and total frequency bands based on tinnitus lateralization (P < .001). CONCLUSION: Non-lateralized tinnitus can be perceived in elderly patients with symmetric and extended high-frequency hearing loss before habituation is achieved at an early stage of tinnitus. However, there was no difference in the questionnaire scores and accompanying symptoms; therefore, it may not be worth managing non-lateralized tinnitus separately from tinnitus in the ear. Cite this article as: Shin S-H, Byun SW, Lee ZY, Park Y, Lee HY. Clinical features of non-lateralized tinnitus. J Int Adv Otol. 2023;19(6):497-502.
- 30 November 2023
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 19 (6) , 497-502
Open AccessClinical Features of Non-Lateralized Tinnitus
BACKGROUND: We aimed to analyze and confirm the clinical features of patients with non-lateralized tinnitus and to identify clues that can be used in their management. METHODS: Data from 469 patients who visited a university hospital complaining of tinnitus between March 2020 and December 2021 were reviewed. The patients’ medical histories, Tinnitus Handicap Inventory, Beck Depression Inventory, and numerical rating scale scores on tinnitus awareness, annoyance, loudness, and effect on life, audiological profiles, and quantitative electroencephalography findings were documented. RESULTS: Forty-nine (10.4%) patients had non-lateralized tinnitus. They were older and had a shorter duration of symptoms (13.91 ± 34.16 months) than patients with bilateral tinnitus (duration: 39.15 ± 80.82 months) (P < .05). The accompanying symptoms, Tinnitus Handicap Inventory scores, and numerical rating scale scores were not significantly different between the 2 groups (P > .05). Patients with non-lateralized tinnitus had worse hearing at 12 kHz on the left side than those with unilateral tinnitus. Hearing asymmetry was least common in non-lateralized tinnitus (n=11/49, 10.4%), followed by bilateral tinnitus (n=54/198, 42.2%) and unilateral tinnitus (n=97/222, 47.3%) (P< .001). Regarding quantitative electroencephalography, there were significant differences in the absolute power of the theta, alpha, beta, gamma, and total frequency bands based on tinnitus lateralization (P < .001). CONCLUSION: Non-lateralized tinnitus can be perceived in elderly patients with symmetric and extended high-frequency hearing loss before habituation is achieved at an early stage of tinnitus. However, there was no difference in the questionnaire scores and accompanying symptoms; therefore, it may not be worth managing non-lateralized tinnitus separately from tinnitus in the ear. Cite this article as: Shin S-H, Byun SW, Lee ZY, Park Y, Lee HY. Clinical features of non-lateralized tinnitus. J Int Adv Otol. 2023;19(6):497-502.
- Open Access
- 1 May 2023
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 19 (3) , 169-174
Short-Term Effect of Adjunctive Transcranial Random Noise Stimulation on Idiopathic Sudden Sensorineural Hearing Loss and Tinnitus: A Preliminary Study
BACKGROUND: Transcranial random noise stimulation has previously been used to manage tinnitus. This study assessed the feasibility of adjuvant transcranial random noise stimulation with conventional steroid treatment for idiopathic sudden sensorineural hearing loss with or without tinnitus. METHODS: Prospective, randomized, single-blind study was conducted in Eulji University hospital. Twenty-four patients with idiopathic sudden sensorineural hearing loss were admitted for treatment between March 2019 and February 2020. The study group received 4 sessions of adjuvant transcranial random noise stimulation (frequency band: 0.1-100 Hz; target, T7/T8; duration: 20 minutes), while the control group received only conventional treatment. Hearing levels at admission, discharge day (day 7), and 4 weeks later and clinical characteristics were assessed. The primary outcome measure was hearing improvement at 4 weeks after neuromodulation. The secondary outcome measure was the presence of tinnitus at 4 weeks. RESULTS: The mean hearing thresholds improved significantly over time (P < .05). Although initial hearing levels did not differ between the 2 groups, the study group had a significantly better hearing at 4 weeks after discharge (P > .05). A significant interaction was also observed between the mean hearing thresholds at various timepoints and transcranial random noise stimulation (P=.001). However, the persistence of tinnitus after treatment did not differ irrespective of the allocation groups. CONCLUSION: Adjuvant transcranial random noise stimulation seems to be a potential treatment option for hearing restoration in patients with idiopathic sudden sensorineural hearing loss without serious complications. However, transcranial random noise stimulation does not seem to alleviate tinnitus. Cite this article as: Shin SH, Byun SW, Lee ZY, Lee HY. Short-term effect of adjunctive transcranial random noise stimulation on idiopathic sudden sensorineural hearing loss and tinnitus: A preliminary study. J Int Adv Otol. 2023;19(3):169-174.
- 1 May 2023
- Published by Caleo in The Journal of International Advanced Otology
- Vol. 19 (3) , 169-174
Open AccessShort-Term Effect of Adjunctive Transcranial Random Noise Stimulation on Idiopathic Sudden Sensorineural Hearing Loss and Tinnitus: A Preliminary Study
BACKGROUND: Transcranial random noise stimulation has previously been used to manage tinnitus. This study assessed the feasibility of adjuvant transcranial random noise stimulation with conventional steroid treatment for idiopathic sudden sensorineural hearing loss with or without tinnitus. METHODS: Prospective, randomized, single-blind study was conducted in Eulji University hospital. Twenty-four patients with idiopathic sudden sensorineural hearing loss were admitted for treatment between March 2019 and February 2020. The study group received 4 sessions of adjuvant transcranial random noise stimulation (frequency band: 0.1-100 Hz; target, T7/T8; duration: 20 minutes), while the control group received only conventional treatment. Hearing levels at admission, discharge day (day 7), and 4 weeks later and clinical characteristics were assessed. The primary outcome measure was hearing improvement at 4 weeks after neuromodulation. The secondary outcome measure was the presence of tinnitus at 4 weeks. RESULTS: The mean hearing thresholds improved significantly over time (P < .05). Although initial hearing levels did not differ between the 2 groups, the study group had a significantly better hearing at 4 weeks after discharge (P > .05). A significant interaction was also observed between the mean hearing thresholds at various timepoints and transcranial random noise stimulation (P=.001). However, the persistence of tinnitus after treatment did not differ irrespective of the allocation groups. CONCLUSION: Adjuvant transcranial random noise stimulation seems to be a potential treatment option for hearing restoration in patients with idiopathic sudden sensorineural hearing loss without serious complications. However, transcranial random noise stimulation does not seem to alleviate tinnitus. Cite this article as: Shin SH, Byun SW, Lee ZY, Lee HY. Short-term effect of adjunctive transcranial random noise stimulation on idiopathic sudden sensorineural hearing loss and tinnitus: A preliminary study. J Int Adv Otol. 2023;19(3):169-174.
- Open Access
- 29 September 2022
- Published by XMLink in Yonsei Medical Journal
- Vol. 63 (11) , 1035-1042
Clinical Findings That Differentiate Co-Occurrence of Hyperacusis and Tinnitus from Tinnitus Alone
Shin SH, et al. Yonsei Med J. 2022 Nov;63(11):1035-1042. https://doi.org/10.3349/ymj.2022.0274
- 29 September 2022
- Published by XMLink in Yonsei Medical Journal
- Vol. 63 (11) , 1035-1042
Open AccessClinical Findings That Differentiate Co-Occurrence of Hyperacusis and Tinnitus from Tinnitus Alone
Shin SH, et al. Yonsei Med J. 2022 Nov;63(11):1035-1042. https://doi.org/10.3349/ymj.2022.0274
- Open Access
- 10 October 2021
- Published by The Korean Audiological Society in Journal of Audiology and Otology
- Vol. 25 (4) , 209-216
Optimal First-Line Therapy for Acute Low-Tone Sensorineural Hearing Loss
Background and Objectives: We aimed to analyze treatment outcomes following different initial management approaches and confirm treatment regimens for acute low-tone sensorineural hearing loss (ALHL) that would yield the best results.Subjects and Methods: We retrospectively analyzed the medical records of 106 patients with ALHL who visited a university hospital’s otology clinic from March 2013 to June 2019. Pure-tone averages at the initial visit and at 2 and 4 weeks after the initial visit were evaluated.Results: Forty-nine patients were enrolled in this study; of them, 41 (83.7%) exhibited complete recovery (CR) at 2 weeks and 43 (87.8%) exhibited CR at 1 month after the initial visit. Regression analysis revealed that CR at 2 weeks after the initial visit was associated with diuretic use [Exp(B): 10.309, 95% confidence interval (CI): 1.007-100]. An initial daily low-dose steroid use was marginally significant [Exp(B): 1.042, 95% CI: 0.997-1.092; p=0.066]. Isolated diuretic use [Exp(B): 25.641, 95% CI: 1.121-90.909; p=0.039] was an independent, good prognostic factor at 1 month after the initial visit. However, other treatment regimens did not affect the final results.Conclusions: A combination of initial daily administration of ≤30 mg prednisolone plus diuretics was sufficient as the first-line treatment for ALHL. High-dose steroids and salvage intratympanic steroid injections can be applied as a second choice; however, the predicted outcome would not be good in that case.
- 10 October 2021
- Published by The Korean Audiological Society in Journal of Audiology and Otology
- Vol. 25 (4) , 209-216
Open AccessOptimal First-Line Therapy for Acute Low-Tone Sensorineural Hearing Loss
Background and Objectives: We aimed to analyze treatment outcomes following different initial management approaches and confirm treatment regimens for acute low-tone sensorineural hearing loss (ALHL) that would yield the best results.Subjects and Methods: We retrospectively analyzed the medical records of 106 patients with ALHL who visited a university hospital’s otology clinic from March 2013 to June 2019. Pure-tone averages at the initial visit and at 2 and 4 weeks after the initial visit were evaluated.Results: Forty-nine patients were enrolled in this study; of them, 41 (83.7%) exhibited complete recovery (CR) at 2 weeks and 43 (87.8%) exhibited CR at 1 month after the initial visit. Regression analysis revealed that CR at 2 weeks after the initial visit was associated with diuretic use [Exp(B): 10.309, 95% confidence interval (CI): 1.007-100]. An initial daily low-dose steroid use was marginally significant [Exp(B): 1.042, 95% CI: 0.997-1.092; p=0.066]. Isolated diuretic use [Exp(B): 25.641, 95% CI: 1.121-90.909; p=0.039] was an independent, good prognostic factor at 1 month after the initial visit. However, other treatment regimens did not affect the final results.Conclusions: A combination of initial daily administration of ≤30 mg prednisolone plus diuretics was sufficient as the first-line treatment for ALHL. High-dose steroids and salvage intratympanic steroid injections can be applied as a second choice; however, the predicted outcome would not be good in that case.